Yearly Archives: 2024

Scitech Development Announces Promising Preliminary Results in Phase 1a Trial for T-cell Non-Hodgkin Lymphoma

Scitech Development Announces Promising Preliminary Results in Phase 1a Trial for T-cell Non-Hodgkin Lymphoma NEWS PROVIDED BY SciTech Development 03 Dec, 2024, 10:00 ET **Multiple Early Partial Responses Alongside Encouraging Safety and Pharmacokinetic Data**   DETROIT, Dec. 3, 2024 /PRNewswire/ — SciTech Development, a clinical-stage pharmaceutical company focused on advancements in cancer treatment, is excited…

SciTech Development Welcomes John Chapman to the Strategic Advisory Board as Senior Financial Advisor

SciTech Development Welcomes John Chapman to the Strategic Advisory Board as Senior Financial Advisor NEWS PROVIDED BY SciTech Development 15 Oct, 2024, 09:00 ET DETROIT, Oct. 15, 2024 /PRNewswire/ — SciTech Development, Inc., a clinical-stage biotechnology company focused on innovative cancer therapeutics, is pleased to announce the addition of John Chapman, CPA, to its Strategic Advisory…

SciTech Development, Inc. Announces Receipt of Drug Supply From The National Cancer Institute (NCI)

SciTech Development, Inc. Announces Receipt of Drug Supply From The National Cancer Institute (NCI) NEWS PROVIDED BY SciTech Development 17 Sept, 2024, 09:00 ET DETROIT, Sept. 17, 2024 /PRNewswire/ — SciTech Development, Inc., a clinical-stage biotechnology company focused on innovative cancer therapeutics, is pleased to announce that the National Cancer Institute (NCI), part of the National…

SciTech Development Raises Additional $3.2M to Expand Clinical Trials for Cancer

SciTech Development Raises Additional $3.2M to Expand Clinical Trials for CancerSciTech accelerates its mission to bring ST-001 to cancer patients. NEWS PROVIDED BY SciTech Development, LLC 04 Jun, 2024, 09:00 ET GROSSE POINTE FARMS, Mich., June 4, 2024 /PRNewswire/ — SciTech Development, a clinical-stage, specialty oncology pharmaceutical company, today announced it has closed an additional…